BMJ  2007;334:447 (3 March), doi:10.1136/bmj.39140.415718.DB

News

New guidelines on preventing heart disease in women propose aspirin for all aged over 65

Owen Dyer

London

The first 150 words of the full text of this article appear below.

New guidelines issued this week by the American Heart Association on the prevention of cardiovascular disease in women propose replacing the Framingham risk assessment method and adopting more aggressive preventive treatment of women who are currently considered at low risk.

The guidelines, which were published online on 19 February in the American Heart Association's journal Circulation (http://circ.ahajournals.org, doi: 10.1161/circulationaha.107.181546), could lead to millions of women taking up low dose aspirin treatment. For the first time, the American Heart Association recommends considering low dose aspirin treatment in all women aged over 65 years, even those not classified as being at high risk.

The Framingham risk function, derived from data gathered over two generations in the Massachusetts town of that name, has been the standard method of assessing heart disease risk since 1998, but the association's panel questioned its usefulness as a standalone tool for assessing risk in women.

. . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ